Related Experiment Videos

Mutations in demyelinating peripheral neuropathies support molecular model of myelin P0-glycoprotein extracellular

D A Kirschner1, R A Saavedra

  • 1Laboratory for the Study of Skeletal Disorders, Children's Hospital, Boston, Massachusetts 02115.

Insights

Homophilic interactions of P0-glycoprotein are crucial for myelin compaction. Molecular modeling explains how mutations cause neuropathies and predicts others, aiding understanding of demyelinating diseases.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • P0-glycoprotein is the major integral membrane protein in peripheral nerve myelin.
  • Homophilic interactions of P0-glycoprotein are essential for myelin adhesion and compaction.
  • Mutations in the P0 gene are linked to demyelinating neuropathies.

Purpose of the Study:

  • To investigate the molecular mechanisms of P0-glycoprotein homophilic interactions.
  • To understand how P0 gene mutations lead to demyelinating neuropathies.
  • To predict potential new mutations causing demyelinating neuropathies.

Main Methods:

  • Molecular modeling of the P0-glycoprotein extracellular domain (P0-ED).
  • Analysis of X-ray diffraction data of myelin inter-membrane spacing.
  • Correlation of identified human P0 gene point-mutations with disease phenotypes.

Main Results:

  • The molecular model identified specific amino acid sidechains involved in P0-P0 homophilic adhesion.
  • The model explains how disease-associated mutations disrupt P0-P0 interactions.
  • The model accounts for compensatory mutations in P0-ED from other species that maintain normal interactions.

Conclusions:

  • Molecular modeling provides a framework for understanding P0-glycoprotein function in myelin.
  • The study elucidates the molecular basis of P0-related neuropathies.
  • This research predicts novel P0 residue substitutions associated with demyelinating neuropathies.

Related Concept Videos